Surgical Science invites investors to Q3 conference call
The call occurs on November 12, 2026, featuring CEO Tom Englund and CFO Anna Ahlberg discussing the interim report for January-September 2026.
See the latest news and media coverage for Surgical Science. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical simulation training and software provider
surgicalscience.comLast updated
In short: Surgical Science reported strong Q2 2026 results with 7% sales growth and improved profitability.
The call occurs on November 12, 2026, featuring CEO Tom Englund and CFO Anna Ahlberg discussing the interim report for January-September 2026.
First half net sales rose 7% to SEK 490.0 million with operating profit reaching SEK 55.6 million compared to prior year losses.
Net sales dropped 6% in SEK but grew 4% in local currencies. Operating profit was SEK 22.9M.
Net sales were SEK 235.5 million, adjusted EBIT SEK 28.3 million (12% margin), and cash and cash equivalents SEK 667.7 million as of 2026-03-31.
Surgical Science, which manufactures virtual reality simulators for surgeons and other medical specialists, reports an operating result of 32.7...
Net sales amounted to SEK 235.5 (250.7) million, a decrease of 6 percent compared with the corresponding period in the preceding year. Calculated in local...
The medical technology company Surgical Science, which plummeted on the stock exchange last autumn and forecast lower revenues in 2026, reports a turnover decrease of 6 percent, but...
Surgical Science Sweden AB (($SE:SUS)) has held its Q4 earnings call. Read on for the main highlights of the call. Surgical Science Sweden’s latest earnings...
Track Surgical Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Surgical Science and other trending companies.